Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Diarrhea and RET[original query] |
---|
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15 (22): 7061-8. Hong David S, Sebti Said M, Newman Robert A, Blaskovich Michelle A, Ye Lei, Gagel Robert F, Moulder Stacy, Wheler Jennifer J, Naing Aung, Tannir Nizar M, Ng Chaan S, Sherman Steven I, El Naggar Adel K, Khan Rabia, Trent Jon, Wright John J, Kurzrock Razel |
Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer. Expert review of clinical pharmacology 2015 Nov 1-11. Krajewska Jolanta, Olczyk Tomasz, Jarzab Barba |
Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer. Clinical lung cancer 2019 2 20 (3): e317-e328. Nokihara Hiroshi, Nishio Makoto, Yamamoto Noboru, Fujiwara Yutaka, Horinouchi Hidehito, Kanda Shintaro, Horiike Atsushi, Ohyanagi Fumiyoshi, Yanagitani Noriko, Nguyen Linh, Yaron Yifah, Borgman Anne, Tamura Tomohi |
A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies. Oncotarget 2020 4 11 (14): 1235-1243. Taylor Matthew H, Alva Ajjai S, Larson Timothy, Szpakowski Sebastian, Purkaystha Das, Amin Alpesh, Karpiak Linda, Piha-Paul Sarina |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: